Keith Orford
Director/Board Member at CALITHERA BIOSCIENCES, INC.
Net worth: 1 $ as of 2024-03-30
Profile
Dr. Keith Orford is a Chief Medical Officer, Executive VP-Clinical at Fog Pharmaceuticals, Inc. He is on the Board of Directors at Calithera Biosciences, Inc. He received his doctorate degree from Georgetown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-29 | 54 ( 0.00% ) | 1 $ | 2024-03-30 |
Keith Orford active positions
| Companies | Position | Start |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 2021-11-04 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2021-10-31 |
Training of Keith Orford
| Georgetown University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Keith Orford
